UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic HER2 Negative Breast Carcinoma|Brain Metastases|Capecitabine|UDT1
Interventions: DRUG: UTD1 combined with capecitabine
Sponsor: Hunan Cancer Hospital